Notopedia is a nonprofit organization with a mission to provide free learning support to all. Click here to donate or volunteer  

Notopedia has a mission to provide free learning support. Click here to donate or volunteer.

Bharat Biotech Shared All Details About Covaxin

fsjd_icon1 ALL NEWS

save
banner
Bharat Biotech Shared All Details About Covaxin
fsjd_icon1 ALL NEWS

Description

Bharat Biotech Shared All Details About Covaxin

Date - 15th Jun 2021

Bharat Biotech shared the full details of all research on its COVID-19 vaccine, Covaxin, on June 12, 2021. Company officials said the complete data from Phase I, Phase II and Phase III Covaxin trials have been scrutinized by regulatory authorities in India. The company also published as many as nine studies on the safety and efficacy of covaxin in five internationally renowned peer-reviewed journals in just twelve months.

Bharat Biotech completed three preclinical studies that included testing candidate vaccines in laboratory animals. The studies were published in the peer-reviewed journal Cellpress. The studies conducted as part of the Phase I trial of Covaxin were aimed at assessing the safety of the vaccine, the immune response, and determining the correct dosage. Phase II clinical trials were conducted to evaluate the safety and ability of the vaccine to induce an immune response.

The studies were published by the peer-reviewed journal Lancet-Infectious Diseases, the company said. In addition, Bharat Biotech stated that full data from studies on neutralizing covaxin variants have already been published in the journals bioRxiv, Clinical Infectious Diseases and the Journal of Travel Medicine.

The neutralization study for the beta and delta variants B.1.351 and B.1.617.2, respectively, and the study for variant B1.1.28 were published in the Journal of Travel Medicine. Studies of variant B.1.617 and alpha variant B.1.1.7 have been published in Clinical Infectious Disease and the Journal of Travel Medicine, respectively.

In an official statement, Bharat Biotech said the published studies are widely cited because of the rigor and breadth that Bharat Biotech brings to its clinical trials. It states that efficacy and safety data for the Phase III study of Covaxin are currently being analyzed and compiled. As previously promised, the company will soon release Phase III test data based on the final analysis.

For more Updates and Information - Click here 

For access to more than 10,000 Colleges - Click here

For Latest Sarkari Jobs - Click here

For Comprehensive Preparation of Competitive Exams - Click here

For School Studies and Exams Preparation across Eight Boards - Click here

The Notopedia Bulletin Board

News about the latest admissions, results, upcoming government jobs, Sarkari exams and many more.

bulletin images
RESULTS

Latest and upcoming results

Explore
bulletin images
ADMISSIONS

Get important alerts

Explore
bulletin images
JOBS

Latest job postings

Explore
bulletin images
SCHOOL

ICSE, CBSE and State Boards

Explore
bulletin images
COLLEGE

Get latest college updates

Explore
bulletin images
EXAM

Latest exam news

Explore
bulletin images
CURRENT AFFAIRS

Latest Current Affairs

Explore


Request For Material

Close Submit
Submit Material

Close Submit